Whit Mayo
Stock Analyst at Leerink Partners
(2.52)
# 2,432
Out of 5,090 analysts
152
Total ratings
52.58%
Success rate
10.55%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Market Perform | $25 → $14 | $15.47 | -9.50% | 11 | Dec 3, 2025 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $22.12 | -23.15% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $330.75 | -6.27% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $3.04 | -17.76% | 5 | Mar 31, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $9.42 | +16.77% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $9.33 | -14.26% | 2 | Nov 19, 2024 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $8.79 | +184.41% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $257.85 | -3.04% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $112.50 | -11.11% | 1 | Jul 10, 2024 | |
| BTSG BrightSpring Health Services | Initiates: Outperform | $15 | $35.79 | -58.09% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $330.91 | +69.23% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $231.08 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $123.61 | -21.53% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $265.44 | +26.21% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $486.70 | -41.24% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $17.19 | +132.69% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.84 | +63.59% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.58 | -41.86% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.65 | +4,499.82% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $210.00 | -73.81% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $85.89 | +103.75% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $19.55 | -2.81% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.57 | +12.04% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $258.39 | -21.44% | 2 | May 1, 2018 |
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Market Perform
Price Target: $25 → $14
Current: $15.47
Upside: -9.50%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $22.12
Upside: -23.15%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $330.75
Upside: -6.27%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $3.04
Upside: -17.76%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $9.42
Upside: +16.77%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $9.33
Upside: -14.26%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $8.79
Upside: +184.41%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $257.85
Upside: -3.04%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $112.50
Upside: -11.11%
BrightSpring Health Services
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $35.79
Upside: -58.09%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $330.91
Upside: +69.23%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $231.08
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $123.61
Upside: -21.53%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $265.44
Upside: +26.21%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $486.70
Upside: -41.24%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $17.19
Upside: +132.69%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.84
Upside: +63.59%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.58
Upside: -41.86%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.65
Upside: +4,499.82%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $210.00
Upside: -73.81%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $85.89
Upside: +103.75%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $19.55
Upside: -2.81%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.57
Upside: +12.04%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $258.39
Upside: -21.44%